×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Sekundärprävention nach Schlaganfall · 2016-11-28 · SPARCL-Studie Atorvastatin 80 mg vs. Placebo 4.731 Patienten mit Schlaganfall/TIA Ergebnisse Atorvastatin: • LDL-Cholesterin
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form